Skip to content

Effect of Lutein in S-26 Gold On Growth And Safety

Effect of Lutein in S-26 Gold on Growth and Safety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00913406
Acronym
S-26 Gold L
Enrollment
232
Registered
2009-06-04
Start date
2005-11-30
Completion date
2006-05-31
Last updated
2009-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Effect of lutein fortification growth healthy term infants

Brief summary

Study to determine if the addition of lutein to infant formula supports healthy growth and development in healthy full term infants.

Interventions

OTHERLutein fortification

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 14 Days
Healthy volunteers
Yes

Inclusion criteria

* Healthy infants aged 0-14 days * Full Term birth and AGA Parent(s) signed informed consent

Exclusion criteria

* Unhealthy infant * Participation in other clinical trial * Use of prohibited medications

Design outcomes

Primary

MeasureTime frame
Weight gain/day in grams/day4 months

Secondary

MeasureTime frame
Collection of adverse experiences4 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026